TURNING POINT THERAPEUTICS I's ticker is TPTX and the CUSIP is 90041T108. A total of 1 filers reported holding TURNING POINT THERAPEUTICS I in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $27,000 | -68.2% | 361 | -88.6% | 0.00% | – |
| Q1 2022 | $85,000 | -81.2% | 3,169 | -66.6% | 0.00% | – |
| Q4 2021 | $453,000 | +225.9% | 9,496 | +352.6% | 0.00% | – |
| Q3 2021 | $139,000 | -89.4% | 2,098 | -87.5% | 0.00% | – |
| Q2 2021 | $1,307,000 | -73.1% | 16,747 | -67.4% | 0.00% | -100.0% |
| Q1 2021 | $4,852,000 | -26.7% | 51,293 | -5.5% | 0.00% | -50.0% |
| Q4 2020 | $6,615,000 | +39.4% | 54,294 | -0.1% | 0.00% | 0.0% |
| Q3 2020 | $4,746,000 | +200.2% | 54,333 | +121.9% | 0.00% | +100.0% |
| Q2 2020 | $1,581,000 | +47.2% | 24,489 | +1.8% | 0.00% | 0.0% |
| Q1 2020 | $1,074,000 | +867.6% | 24,067 | +1254.4% | 0.00% | – |
| Q4 2019 | $111,000 | +2120.0% | 1,777 | +1486.6% | 0.00% | – |
| Q2 2019 | $5,000 | – | 112 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 2,750,000 | $260,122,000 | 5.80% |
| Burrage Capital Management LLC | 72,164 | $6,826,000 | 5.53% |
| Consonance Capital Management LP | 450,396 | $42,603,000 | 4.54% |
| MPM BioImpact LLC | 269,186 | $25,462,000 | 3.20% |
| Orbimed Advisors | 2,361,327 | $223,358,000 | 2.09% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 81,541 | $7,711,000 | 2.04% |
| SECTORAL ASSET MANAGEMENT INC | 257,879 | $24,393,000 | 1.85% |
| Nicholas Investment Partners, LP | 218,847 | $20,701,000 | 1.44% |
| Logos Global Management LP | 140,000 | $13,243,000 | 1.29% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 16,741 | $1,584,000 | 0.86% |